BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15735243)

  • 1. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
    Ferraro AJ; Day CJ; Drayson MT; Savage CO
    Nephrol Dial Transplant; 2005 Mar; 20(3):622-5. PubMed ID: 15735243
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Rituximab for refractory head and neck Wegener's granulomatosis.
    Ibrahim AS
    Clin Otolaryngol; 2009 Dec; 34(6):581-2. PubMed ID: 20070778
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory Wegener's meningitis treated with rituximab.
    Bawa S; Mukhtyar C; Edmonds S; Webley M
    J Rheumatol; 2007 Apr; 34(4):900-1. PubMed ID: 17407257
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?
    Sneller MC
    Arthritis Rheum; 2005 Jan; 52(1):1-5. PubMed ID: 15641069
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
    Antoniu SA
    Curr Opin Investig Drugs; 2007 Nov; 8(11):927-32. PubMed ID: 17979026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide: sometimes the drug of choice in Wegener's granulomatosis?
    Pedersen RS; Jensen DM
    Nephrol Dial Transplant; 1995; 10(9):1759-61. PubMed ID: 8559502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab efficiency in refractory Wegener's granulomatosis.
    Rozin A
    Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
    Cheung CM; Murray PI; Savage CO
    Br J Ophthalmol; 2005 Nov; 89(11):1542. PubMed ID: 16234479
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of rituximab in Wegener's granulomatosis: comment on the article by Wong.
    Sánchez-Cano D; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Nephrol Dial Transplant; 2007 Mar; 22(3):958-9; author reply 959. PubMed ID: 17237478
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
    Kontkanen M; Paimela L; Kaarniranta K
    Acta Ophthalmol; 2010 May; 88(3):e96-7. PubMed ID: 19758399
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab.
    Staines KS; Higgins B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):76-80. PubMed ID: 19451001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.
    Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
    J Clin Rheumatol; 2008 Apr; 14(2):92-3. PubMed ID: 18391678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Wegener's granulomatosis: the view from two non-nephrologists.
    Gross WL; Rasmussen N
    Nephrol Dial Transplant; 1994; 9(9):1219-22. PubMed ID: 7816277
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy.
    Briani C; Zambello R; Cavallaro T; Ferrari S; Lucchetta M; Pollanz S; Grisold W
    J Peripher Nerv Syst; 2009 Jun; 14(2):146-8. PubMed ID: 19691537
    [No Abstract]   [Full Text] [Related]  

  • 19. Recovery from multiple cranial nerve palsy of Wegener's granulomatosis with infliximab.
    Fujikawa K; Kawakami A; Eguchi K
    J Rheumatol; 2008 Jul; 35(7):1471-2. PubMed ID: 18609728
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
    Wong CF
    J Clin Rheumatol; 2008 Apr; 14(2):61-4. PubMed ID: 18391671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.